This preview shows pages 1–2. Sign up to view the full content.
This preview has intentionally blurred sections. Sign up to view the full version.View Full Document
Unformatted text preview: Universities told to consider dope tests as student use of 'smart drugs' soars Cambridge scientist calls for ethical debate on drugs bought on internet that boost alertness and attention. Universities must investigate measures, including random dope testing, to tackle the increasing use of cognitive enhancement drugs by students for exams, a leading behavioural neuroscientist warns. Student use of drugs, such as Ritalin and modafinil, available over the internet and used to increase the brain's alertness, had "enormous implications for universities", said Barbara Sahakian, a professor of clinical neuropsychology at Cambridge University's psychiatry department. Normally prescribed for neurological disorders including Alzheimer's disease, attention deficit hyperactivity disorder (ADHD) and narcolepsy, such drugs boost acetylcholine in the brain, improving alertness and attention. Their use has prompted concerns that they could give students an unfair advantage. "This is something that universities really have to discuss. They should have an unfair advantage....
View Full Document
- Fall '08